News About: Goverment
Health insurance covers Galvusmet
Galvusmet, a twice-daily combination of vildagliptin and metformin, get listed in national health insurance from this month, according to Novartis Korea and Handok Pharm.
Two strengths of Glavusmet 50/850 mg and 50...
Health Insurance Reform Committee to be launched
The National Health Insurance Corporation (NHIC) is rolling up its sleeves to put its key health insurance reform drive into high gear.
To this end, the corporation said on March 2 that it will newly set up a Healt...
Incentive drugs top 4,106
A total of 4,106 low-drugs could be dispensed in pharmacy as of January this year due to increased bioequivalence-tested drugs, the Health Insurance Review Assessment and Service said on March 1.
The number of ince...
Koreat to introduce CTD format this month
The Korea Food and Drug Administration says it has introduced a Common Technical Document (CTD) format system this month.
The CTS is a set of specification for application dossier for the registration of Medicines ...
Korea to expand herbal insurance coverage to rare, intractable disease
People suffering from rare or intractable diseases will pay less medical costs from the end of this year thanks to the government’s plan to restructure the national herbal health insurance scheme.
The government ex...
Bioequivalence to become compulsory for generic drugs
From this year, all generic drugs produced in Korea must prove they are equivalent to the patented medicines on which they are modeled, the Korea Food and Drug Administration said.
Generic drugs would be obliged to...
Asthma forecast system to be operated in March
The weather forecast may be a strong predictor of how asthma suffers going to feel.
We all know these patients who blame the weather for their severity. But proving these claims has been a bit more elusive.
The...
Generic drug prices to fall by 40 percent
When 4-5 first generic drug gets listed for insurance coverage, the price of the next generic drug will be decreased by almost 40 percent from this March, the Ministry of Health and Welfare said recently.
A drug i...
Drugmakers call for evidence-based approach to new drug pricing policy
The so-called positive list system reinforces the government's rash approach to shaping policies, according to a joint statement issued by the Korea Pharmaceutical Manufacturers Association (KPMA) and the Korean Resea...
Government to evaluate quality of oriental medicines
The Korea Food and Drug Administration said it will evaluate the raw materials contained in oriental medicines, including Dong-A Pharm’s Stillen, to ensure their quality, following verification work of SK Chemicals’ J...
